U.S. Markets close in 2 hrs 54 mins

Laboratorios Farmaceuticos ROVI, S.A. (ROVI.MC)

MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
15.86-0.14 (-0.88%)
At close: 5:35PM CEST
Full screen
Previous Close16.00
Open15.86
Bid15.72 x 8400
Ask16.46 x 15000
Day's Range15.86 - 15.86
52 Week Range10.80 - 18.75
Volume612
Avg. Volume3,417
Market Cap782.16M
BetaN/A
PE Ratio (TTM)32.77
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look
    Capital Cube5 months ago

    Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceLaboratorios Farmaceúticos Rovi SA relative valuation is now OVERVALUED. It was previously rated UNDERVALUED, and has a fundamental analysis score of 78. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.
    Capital Cube7 months ago

    Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now UNDERVALUED. It was previously rated OVERVALUED, and has a fundamental analysis score of 72. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors
    Capital Cubelast year

    Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 50. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)